US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nexentis Technologies Inc

1.77

-0.0300-1.67%

Post-market: 1.880.1100+6.21%19:57 EDT

Volume:7K

Turnover:12.70K

Market Cap:2.57M

PE:-0.03

High:1.90

Open:1.88

Low:1.70

Close:1.80

52wk High:58.75

52wk Low:1.43

Shares:1.45M

Float Shares:1.15M

Volume Ratio:0.32

T/O Rate:0.62%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-55.2923

EPS(LYR):-34.9551

ROE:-450.32%

ROA:-28.57%

PB:1.35

PE(LYR):-0.05

Loading ...

Overview Company News Filings

Nexentis Q2 FY26 Net Loss Widens 154% to $11.16 Million

Nexentis Technologies Replaces KPMG Israel with Deloitte Israel as Auditor

Nexentis Technologies Subsidiary MitoCareX Bio Selects Transport Protein Candidate for Drug Discovery Campaign

Nexentis Unit Mitocarex Bio Expands SLC Transporter Analysis for Drug Discovery

Nexentis Announces Monetization of Part of Its Melz Solar Investment at $14.5 Million Project Valuation – Significant Premium to Initial Investment

THOMSON REUTERS

Nexentis Monetizes Part of Melz Solar Investment at USD 14.5 Million Valuation

Nexentis Technologies Inc: Offers 410,998 Shares at $7.056 per Share - SEC Filing

THOMSON REUTERS

Top Premarket Decliners

MT Newswires Live

Stocks to Watch: Primoris Services, Avis Budget, Nexentis Technologies

Nexentis Technologies Slides on Private Offerings

Nexentis Technologies prices private placement of 410,998 warrants at $7.06 each

Top Midday Gainers

MT Newswires Live

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:35 AM

Nexentis Technologies - Mitocarex to Retain Full Control Over Discovery Programs and Candidates

THOMSON REUTERS

Nexentis Technologies - Announces Mitocarex Engagement With Boltz for AI-Driven Slc Small-Molecule Discovery

THOMSON REUTERS

Nexentis unit MitoCareX partners with Boltz on AI-driven SLC small-molecule discovery

Nexentis Technologies Announces International AI Drug Discovery Initiative Between MitoCareX Bio and Boltz to Accelerate Novel SLC Small-Molecule Discovery

Nexentis Technologies - Subsidiary Mitocarex Completes Broad Analysis of Human Slc Transport Proteins

THOMSON REUTERS

Nexentis Technologies - Mitocarex Identifies Additional Slc Proteins Compatible With Mitoline Ruleset

THOMSON REUTERS

Nexentis unit MitoCareX completes broad structural analysis of human SLC transport proteins

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/NXTS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NXTS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NXTS\",,,,,undefined,":{"symbol":"NXTS","market":"US","secType":"STK","nameCN":"Nexentis Technologies Inc","latestPrice":1.77,"timestamp":1787342400000,"preClose":1.8,"halted":0,"volume":7102,"hourTrading":{"tag":"盘后","latestPrice":1.88,"preClose":1.77,"latestTime":"19:57 EDT","volume":762,"amount":1353.47,"timestamp":1787356653310,"change":0.11,"changeRate":0.062147,"amplitude":0.07774},"delay":0,"changeRate":-0.01666666666666668,"floatShares":1149600,"shares":1453300,"eps":-55.292328,"marketStatus":"Market Closed","change":-0.03,"latestTime":"08-21 16:00:00 EDT","open":1.88,"high":1.896,"low":1.7,"amount":12696.4854476,"amplitude":0.108889,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-55.292328,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1.8,"preHourTrading":{"tag":"盘前","latestPrice":1.86,"preClose":1.8,"latestTime":"09:29 EDT","volume":269,"amount":485.98029579999996,"timestamp":1787318999080,"change":0.06,"changeRate":0.033333,"amplitude":0.038889},"postHourTrading":{"tag":"盘后","latestPrice":1.88,"preClose":1.77,"latestTime":"19:57 EDT","volume":762,"amount":1353.47,"timestamp":1787356653310,"change":0.11,"changeRate":0.062147,"amplitude":0.07774},"volumeRatio":0.3222919317176024},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NXTS\",,,,,undefined,":{"symbol":"NXTS","floatShares":1149600,"roa":"-28.57%","roe":"-450.32%","lyrEps":-34.955117,"volumeRatio":0.3222919317176024,"shares":1453300,"dividePrice":0,"high":1.896,"amplitude":0.108889,"preClose":1.8,"low":1.7,"week52Low":1.4301,"pbRate":"1.35","psRate":"12.31","week52High":58.751,"institutionHeld":0,"latestPrice":1.77,"eps":-55.292328,"divideRate":0,"volume":7102,"delay":0,"ttmEps":-55.292328,"open":1.88,"prevYearClose":11.76,"prevWeekClose":1.91,"prevMonthClose":1.71,"prevQuarterClose":4.31,"fiveDayClose":1.91,"twentyDayClose":1.8,"sixtyDayClose":4.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NXTS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"NXTS","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-25.96},{"market":"US","date":"2026-05-14","symbol":"NXTS","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"post","actualEps":-12.1},{"market":"US","date":"2026-04-08","symbol":"NXTS","defaultRemindTime":1775655000000,"type":"split","dateTimestamp":1775620800000,"forFactor":7,"toFactor":1,"ratio":7},{"date":"2026-03-31","symbol":"NXTS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774987200000,"name":null,"time":"Post-Mkt","dateTimestamp":1774929600000,"actualEps":null},{"market":"US","date":"2025-11-13","symbol":"NXTS","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-8.29}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NXTS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NXTS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NXTS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NXTS","date":"2026-08-21","current":-0.032012,"percent":0.833333,"low":-1.066842,"twenty":-0.751348,"median":-0.380998,"eighty":-0.192902,"high":-0.087052,"avg":-0.424129,"sd":0.251452,"marketCap":2615999},"quantilePoints":[{"date":"2026-02-27","current":-0.435167,"twenty":-0.435167,"median":-0.435167,"eighty":-0.435167,"marketCap":2892119},{"date":"2026-03-06","current":-0.397016,"twenty":-0.415225,"median":-0.395474,"eighty":-0.392918,"marketCap":2638567},{"date":"2026-03-13","current":-0.363639,"twenty":-0.415225,"median":-0.392918,"eighty":-0.384468,"marketCap":2416744},{"date":"2026-03-20","current":-0.308842,"twenty":-0.397016,"median":-0.38658,"eighty":-0.344965,"marketCap":2052562},{"date":"2026-03-27","current":-0.285858,"twenty":-0.393932,"median":-0.363723,"eighty":-0.300138,"marketCap":1899813},{"date":"2026-04-02","current":-0.277831,"twenty":-0.393121,"median":-0.344965,"eighty":-0.278879,"marketCap":1846463},{"date":"2026-04-10","current":-0.848002,"twenty":-0.4161,"median":-0.367697,"eighty":-0.282571,"marketCap":3395402},{"date":"2026-04-17","current":-0.723994,"twenty":-0.439299,"median":-0.384468,"eighty":-0.285385,"marketCap":2898870},{"date":"2026-04-24","current":-0.913654,"twenty":-0.754631,"median":-0.392896,"eighty":-0.297282,"marketCap":3658271},{"date":"2026-05-01","current":-0.869886,"twenty":-0.840693,"median":-0.397016,"eighty":-0.307101,"marketCap":3483025},{"date":"2026-05-08","current":-1.066842,"twenty":-0.847273,"median":-0.423688,"eighty":-0.318981,"marketCap":4271634},{"date":"2026-05-15","current":-0.846179,"twenty":-0.852197,"median":-0.435167,"eighty":-0.327296,"marketCap":3388100},{"date":"2026-05-22","current":-0.343676,"twenty":-0.848732,"median":-0.423688,"eighty":-0.328308,"marketCap":3227457},{"date":"2026-05-29","current":-0.389551,"twenty":-0.847455,"median":-0.408608,"eighty":-0.337702,"marketCap":3658271},{"date":"2026-06-05","current":-0.393439,"twenty":-0.846544,"median":-0.402769,"eighty":-0.343909,"marketCap":3694781},{"date":"2026-06-12","current":-0.389551,"twenty":-0.845085,"median":-0.400825,"eighty":-0.344605,"marketCap":3658271},{"date":"2026-06-18","current":-0.41521,"twenty":-0.843625,"median":-0.40238,"eighty":-0.345693,"marketCap":3899235},{"date":"2026-06-26","current":-0.404324,"twenty":-0.843625,"median":-0.404324,"eighty":-0.347408,"marketCap":3797008},{"date":"2026-07-02","current":-0.346912,"twenty":-0.841798,"median":-0.401991,"eighty":-0.346811,"marketCap":3257847},{"date":"2026-07-10","current":-0.296353,"twenty":-0.837411,"median":-0.396005,"eighty":-0.33693,"marketCap":2783048},{"date":"2026-07-17","current":-0.192902,"twenty":-0.831221,"median":-0.393439,"eighty":-0.322528,"marketCap":1811538},{"date":"2026-07-24","current":-0.148565,"twenty":-0.81881,"median":-0.391991,"eighty":-0.29711,"marketCap":1395176},{"date":"2026-07-31","current":-0.120563,"twenty":-0.775056,"median":-0.389551,"eighty":-0.285858,"marketCap":1132211},{"date":"2026-08-07","current":-0.149732,"twenty":-0.773232,"median":-0.388693,"eighty":-0.278845,"marketCap":1406133},{"date":"2026-08-14","current":-0.151677,"twenty":-0.767761,"median":-0.384288,"eighty":-0.263889,"marketCap":1424395},{"date":"2026-08-21","current":-0.163224,"twenty":-0.751348,"median":-0.380998,"eighty":-0.192902,"marketCap":2615999}],"updateTime":1787512844009},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NXTS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659678511","title":"Nexentis Q2 FY26 Net Loss Widens 154% to $11.16 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659678511","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659678511?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:17","pubTimestamp":1786652243,"startTime":"0","endTime":"0","summary":"Nexentis Q2 FY26 net loss widens 154% to $11.16 millionNexentis reported a net loss from continuing operations of USD 11.16 million for the quarter ended June 30, 2026, widening 154% year over year.Fi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL753ZPJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTS","BK4093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657663572","title":"Nexentis Technologies Replaces KPMG Israel with Deloitte Israel as Auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=2657663572","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657663572?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:47","pubTimestamp":1786049271,"startTime":"0","endTime":"0","summary":"Nexentis Technologies replaces KPMG Israel with Deloitte Israel as auditorNexentis Technologies dismissed KPMG Israel as independent auditor, effective Aug. 6, 2026.KPMG’s audit reports for 2025 and 2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDLMhTGF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4093","NXTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654207002","title":"Nexentis Technologies Subsidiary MitoCareX Bio Selects Transport Protein Candidate for Drug Discovery Campaign","url":"https://stock-news.laohu8.com/highlight/detail?id=2654207002","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654207002?lang=en_us&edition=fundamental","pubTime":"2026-07-28 20:06","pubTimestamp":1785240360,"startTime":"0","endTime":"0","summary":"Following its broad structural analysis of the human SLC transport protein family, MitoCareX advances from a pool of candidates to a prioritized target, reflecting continued execution of its MITOLINE-","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/28/3334228/0/en/Nexentis-Technologies-Subsidiary-MitoCareX-Bio-Selects-Transport-Protein-Candidate-for-Drug-Discovery-Campaign.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTS","BK4093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649874299","title":"Nexentis Unit Mitocarex Bio Expands SLC Transporter Analysis for Drug Discovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2649874299","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649874299?lang=en_us&edition=fundamental","pubTime":"2026-07-07 20:25","pubTimestamp":1783427131,"startTime":"0","endTime":"0","summary":"Nexentis unit MitoCareX Bio expands SLC transporter analysis for drug discoveryNexentis unit MitoCareX Bio completed a broad analysis of SLC transport proteins to expand targets for small-molecule dru","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDL7KDMvf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BN0W2W23.USD","BK4112","BCDF","SG9999014039.USD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","SG9999014005.SGD","LU2095319765.USD","SG9999014013.SGD","LU2210150020.SGD","NXTS","BK4093","SG9999014021.USD","IE00BKPKM429.USD","LU0314104364.USD","IE00BGHQF748.EUR","NDAQ","BK4585","BK4588","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647371587","title":"Nexentis Announces Monetization of Part of Its Melz Solar Investment at $14.5 Million Project Valuation – Significant Premium to Initial Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2647371587","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647371587?lang=en_us&edition=fundamental","pubTime":"2026-06-29 20:21","pubTimestamp":1782735673,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nFWN43105A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4093","NXTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647371585","title":"Nexentis Monetizes Part of Melz Solar Investment at USD 14.5 Million Valuation","url":"https://stock-news.laohu8.com/highlight/detail?id=2647371585","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647371585?lang=en_us&edition=fundamental","pubTime":"2026-06-29 20:20","pubTimestamp":1782735618,"startTime":"0","endTime":"0","summary":"Nexentis monetizes part of Melz solar investment at USD 14.5 million valuationNexentis signed an addendum to monetize part of its Melz solar PV investment in Germany at a USD 14.5 million project valu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDLbzLY4x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4093","LU2095319765.USD","BK4588","IE00B64PRP62.GBP","SG9999014005.SGD","NXTS","NDAQ","SG9999014021.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","LU2210150020.SGD","IE00BKPKM429.USD","IE00BGHQF748.EUR","SG9999014039.USD","LU0314104364.USD","IE00B3QW5Z07.USD","LU2210149790.SGD","SG9999014013.SGD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645342278","title":"Nexentis Technologies Inc: Offers 410,998 Shares at $7.056 per Share - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2645342278","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645342278?lang=en_us&edition=fundamental","pubTime":"2026-06-23 22:05","pubTimestamp":1782223556,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nFWN42V0IZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NXTS","BK4093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645083372","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2645083372","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645083372?lang=en_us&edition=fundamental","pubTime":"2026-06-23 19:35","pubTimestamp":1782214502,"startTime":"0","endTime":"0","summary":"Nexentis Technologies (NXTS) shares were down 49% in recent Tuesday premarket activity, reversing the previous session's 156% rally.Wheeler Real Estate Investment Trust (WHLR) shares were down 37% aft","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2362541513.USD","IE00B7SZL793.SGD","LU0054578231.USD","PRIM","WHLR","BK4129","BK4231","IE00B19Z4B17.USD","IE0031619046.USD","BK4093","NXTS","BK4080","BK4230","TNON","WETO","LU2362541273.HKD","LU2362540622.SGD","BK4082","IE00B66KJ199.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645293003","title":"Stocks to Watch: Primoris Services, Avis Budget, Nexentis Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2645293003","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645293003?lang=en_us&edition=fundamental","pubTime":"2026-06-23 06:41","pubTimestamp":1782168060,"startTime":"0","endTime":"0","summary":"Primoris Services cut its full-year outlook, warning of second-quarter headwinds in its renewables business, and said its chief operating officer left the company. The stock slid 33%, to $72.50, after the bell on Monday.Avis Budget Group is set to receive $650 million in a settlement agreement with Pentwater Capital Management. Shares were up 6.5%, to $198.38, in after-hours trading.Nexentis Technologies said it would sell shares to some investors below the company's Monday closing price. Shares plummeted 46%, to $7.07.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541513.USD","BK4093","IE00B19Z4B17.USD","PRIM","IE00B7SZL793.SGD","BK4022","BK4129","CAR","BK4230","LU2362541273.HKD","LU2362540622.SGD","LU0054578231.USD","IE0031619046.USD","IE00B66KJ199.SGD","NXTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645008246","title":"Nexentis Technologies Slides on Private Offerings","url":"https://stock-news.laohu8.com/highlight/detail?id=2645008246","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645008246?lang=en_us&edition=fundamental","pubTime":"2026-06-23 05:41","pubTimestamp":1782164460,"startTime":"0","endTime":"0","summary":"Shares of Nexentis Technologies sank after the company said it would sell shares to certain investors at about $7 apiece, below Monday's closing price.The stock dropped 44%, to $6.90, after hours, giving back much of the surge it got during the trading day that saw it close at $13. It finished trading last week at $5.08.Investors rallied behind the stock after Nexentis said on Monday morning that its subsidiary was working with artificial-intelligence research lab Boltz to accelerate the discovery of new cancer-fighting small-molecule drug candidates.After the closing bell, Nexentis said it agreed to issue and sell nearly 411,000 shares to certain investors in a direct offering at a price of just under $7.06 a share. It has also agreed to issue those investors another roughly 411,000 warrants, each of which can be exercised to buy a share at just under $7.06.The company expects to receive about $2.9 million in gross proceeds from the offerings, which is set to close on Wednesday.Nexent","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTS","BK4093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645070231","title":"Nexentis Technologies prices private placement of 410,998 warrants at $7.06 each","url":"https://stock-news.laohu8.com/highlight/detail?id=2645070231","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645070231?lang=en_us&edition=fundamental","pubTime":"2026-06-23 04:49","pubTimestamp":1782161387,"startTime":"0","endTime":"0","summary":"Nexentis Technologies entered a private placement on June 22, 2026, issuing 410,998 unregistered warrants alongside a registered direct stock sale.Warrants cover 410,998 common shares, exercisable immediately at USD 7.06 per share, with a five-year term.Resale registration for warrant shares due within 30 days of closing; effectiveness targeted within 60 days.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nexentis Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 22, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL1fmPWd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTS","BK4093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645071067","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2645071067","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645071067?lang=en_us&edition=fundamental","pubTime":"2026-06-23 02:07","pubTimestamp":1782151648,"startTime":"0","endTime":"0","summary":"Nexentis Technologies  said Monday its subsidiary, MitoCareX Bio, has entered into an engagement with Boltz, an AI research lab, to accelerate the identification of novel small-molecule scaffolds targeting selected solute carrier proteins of interest to MitoCareX's pipeline.Shares jumped over 200% as trading volume catapulted to over 55 million from a daily average of about 208,000.AbbVie  agreed to acquire Apogee Therapeutics  for $135.11 per share in cash for a total equity value of $10.9 billion, the companies said Monday.Shares of Apogee soared 47%, with intraday trading volume of over 47.1 million against a daily average of about 975,000.Definium Therapeutics  reported positive topline results from a phase 3 Emerge study of DT120 orally disintegrating tablet in major depressive disorder.RBC Capital raised its price target to $57 from $36, while maintaining its outperform rating.Shares surged 52% amid a jump in intraday trading volume to over 16 million from a daily average of roug","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0211328371.USD","LU2089283258.USD","IE00BSNM7G36.USD","LU1934455194.USD","LU1074936037.SGD","LU1551013425.SGD","APGE","LU0708994859.HKD","ABBV","IE00BBT3K403.USD","IE0000B7K699.USD","LU2237443549.SGD","LU1162221912.USD","LU2133065610.SGD","IE00BFTCPJ56.SGD","LU1718418525.SGD","IE000F7OJYX1.SGD","IE00B4R5TH58.HKD","IE00B42XCP33.USD","IE000SO60NU8.SGD","DFTX","LU0256863902.USD","IE00B3PB1722.GBP","LU0553294199.USD","LU0661504455.SGD","LU2468319806.SGD","LU1983299246.USD","IE00BJJMRZ35.SGD","LU1934455277.USD","LU1839511570.USD","LU1244550577.SGD","LU0069063385.USD","LU0859254822.USD","LU0545039389.USD","LU0868494708.USD","LU0170899867.USD","LU0211327993.USD","LU0795875086.SGD","SG9999011175.SGD","IE00BDGV0183.EUR","LU2023251221.USD","LU0868494617.USD","LU1934455863.HKD","BK4533","LU0456855351.SGD","LU0985320562.USD","LU1291159041.SGD","NXTS","BK4566","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645974020","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:35 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2645974020","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645974020?lang=en_us&edition=fundamental","pubTime":"2026-06-22 21:35","pubTimestamp":1782135324,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:35 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nAQN2M4LDL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4093","NXTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645402237","title":"Nexentis Technologies - Mitocarex to Retain Full Control Over Discovery Programs and Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=2645402237","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645402237?lang=en_us&edition=fundamental","pubTime":"2026-06-22 20:23","pubTimestamp":1782131005,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nFWN42U0JS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NXTS","BK4093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645022377","title":"Nexentis Technologies - Announces Mitocarex Engagement With Boltz for AI-Driven Slc Small-Molecule Discovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2645022377","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645022377?lang=en_us&edition=fundamental","pubTime":"2026-06-22 20:23","pubTimestamp":1782131005,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nFWN42U0JS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NXTS","BK4093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645022326","title":"Nexentis unit MitoCareX partners with Boltz on AI-driven SLC small-molecule discovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2645022326","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645022326?lang=en_us&edition=fundamental","pubTime":"2026-06-22 20:22","pubTimestamp":1782130961,"startTime":"0","endTime":"0","summary":"Nexentis subsidiary MitoCareX entered an engagement with Boltz to speed AI-led discovery of small molecules targeting selected SLC transporters.Collaboration combines MitoCareX’s MITOLINE-enabled 3D structural modeling with Boltz foundation models for structure prediction, binding affinity, screening, molecule design.Initial work targets a defined set of SLC proteins; scope may expand if early virtual screening results support additional discovery programs.MitoCareX retains control of its programs and any candidates advanced using the combined platform.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL8HlJSW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014005.SGD","SG9999014013.SGD","NDAQ","IE00BGHQF748.EUR","LU0314104364.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","LU2210150020.SGD","LU2095319765.USD","BK4585","IE00BN0W2W23.USD","BK4588","SG9999014021.USD","BK4093","IE00B64PRP62.GBP","NXTS","IE00BKPKM429.USD","BK4112","IE00B3QW5Z07.USD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645225890","title":"Nexentis Technologies Announces International AI Drug Discovery Initiative Between MitoCareX Bio and Boltz to Accelerate Novel SLC Small-Molecule Discovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2645225890","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645225890?lang=en_us&edition=fundamental","pubTime":"2026-06-22 20:22","pubTimestamp":1782130920,"startTime":"0","endTime":"0","summary":"MITOLINE-Enabled 3D Structural Modeling and Boltz AI Capabilities to Be Combined by MitoCareX in a Synergistic Virtual Screening Campaign for selected Transporter Targets Neve Yarak, Israel, June  22,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/22/3315270/0/en/Nexentis-Technologies-Announces-International-AI-Drug-Discovery-Initiative-Between-MitoCareX-Bio-and-Boltz-to-Accelerate-Novel-SLC-Small-Molecule-Discovery.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHAT","AAQC","BK4093","ARTY","AGIX","AIPO","NXTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644743158","title":"Nexentis Technologies - Subsidiary Mitocarex Completes Broad Analysis of Human Slc Transport Proteins","url":"https://stock-news.laohu8.com/highlight/detail?id=2644743158","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644743158?lang=en_us&edition=fundamental","pubTime":"2026-06-17 19:32","pubTimestamp":1781695967,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nFWN42P08N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NXTS","BK4093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644274311","title":"Nexentis Technologies - Mitocarex Identifies Additional Slc Proteins Compatible With Mitoline Ruleset","url":"https://stock-news.laohu8.com/highlight/detail?id=2644274311","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644274311?lang=en_us&edition=fundamental","pubTime":"2026-06-17 19:32","pubTimestamp":1781695967,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nFWN42P08N:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NXTS","BK4093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644074316","title":"Nexentis unit MitoCareX completes broad structural analysis of human SLC transport proteins","url":"https://stock-news.laohu8.com/highlight/detail?id=2644074316","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644074316?lang=en_us&edition=fundamental","pubTime":"2026-06-17 19:32","pubTimestamp":1781695945,"startTime":"0","endTime":"0","summary":"Nexentis subsidiary MitoCareX completed a broad structural analysis of human SLC transport proteins to expand its small-molecule discovery engine.Work extends MITOLINE, previously used for mitochondrial SLC25 carriers, to identify non-SLC25 targets compatible with its modeling ruleset.MitoCareX plans to use MITOLINE-derived 3D models in virtual screening for selected non-mitochondrial SLC targets.Move could widen MitoCareX’s addressable transporter set for hard-to-treat cancers and inflammatory metabolic diseases.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL6JzrNF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4588","IE00BN0W2T93.GBP","NDAQ","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","SG9999014013.SGD","SG9999014005.SGD","BK4112","BK4585","LU0314104364.USD","IE00BN0W2V16.EUR","LU2095319765.USD","BK4093","NXTS","IE00BN0W2W23.USD","SG9999014039.USD","IE00BKPKM429.USD","SG9999014021.USD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":53,"code":"91000000","status":"200"}]}}